These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30483473)

  • 1. Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers.
    Rossig C; Kailayangiri S; Jamitzky S; Altvater B
    Front Oncol; 2018; 8():513. PubMed ID: 30483473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of GD2 ganglioside: implications for cancer immunotherapy.
    Machy P; Mortier E; Birklé S
    Front Pharmacol; 2023; 14():1249929. PubMed ID: 37670947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
    Ruan S; Lloyd KO
    Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model.
    Richman SA; Nunez-Cruz S; Moghimi B; Li LZ; Gershenson ZT; Mourelatos Z; Barrett DM; Grupp SA; Milone MC
    Cancer Immunol Res; 2018 Jan; 6(1):36-46. PubMed ID: 29180536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.
    Chen Y; Sun C; Landoni E; Metelitsa L; Dotti G; Savoldo B
    Clin Cancer Res; 2019 May; 25(9):2915-2924. PubMed ID: 30617136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of gangliosides in malignant properties of melanomas.
    Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
    PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
    Nishio M; Furukawa K
    Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    Cheresh DA; Pierschbacher MD; Herzig MA; Mujoo K
    J Cell Biol; 1986 Mar; 102(3):688-96. PubMed ID: 3005335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
    Berois N; Pittini A; Osinaga E
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
    Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
    Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.
    Long AH; Highfill SL; Cui Y; Smith JP; Walker AJ; Ramakrishna S; El-Etriby R; Galli S; Tsokos MG; Orentas RJ; Mackall CL
    Cancer Immunol Res; 2016 Oct; 4(10):869-880. PubMed ID: 27549124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.
    Prapa M; Caldrer S; Spano C; Bestagno M; Golinelli G; Grisendi G; Petrachi T; Conte P; Horwitz EM; Campana D; Paolucci P; Dominici M
    Oncotarget; 2015 Sep; 6(28):24884-94. PubMed ID: 26298772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac
    Cavdarli S; Dewald JH; Yamakawa N; Guérardel Y; Terme M; Le Doussal JM; Delannoy P; Groux-Degroote S
    Glycoconj J; 2019 Feb; 36(1):79-90. PubMed ID: 30612272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.
    Yu J; Wu X; Yan J; Yu H; Xu L; Chi Z; Sheng X; Si L; Cui C; Dai J; Ma M; Xu T; Kong Y; Guo J
    J Hematol Oncol; 2018 Jan; 11(1):1. PubMed ID: 29298689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis.
    Horwacik I; Rokita H
    Apoptosis; 2015 May; 20(5):679-88. PubMed ID: 25673107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
    Hersey P
    Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.
    Zhang S; Cordon-Cardo C; Zhang HS; Reuter VE; Adluri S; Hamilton WB; Lloyd KO; Livingston PO
    Int J Cancer; 1997 Sep; 73(1):42-9. PubMed ID: 9334808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.
    Dobrenkov K; Ostrovnaya I; Gu J; Cheung IY; Cheung NK
    Pediatr Blood Cancer; 2016 Oct; 63(10):1780-5. PubMed ID: 27304202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.